Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Angiotensin I Converting Enzyme 1 Antikörper

ACE Reaktivität: Human FACS Wirt: Maus Monoclonal BB9 unconjugated
Produktnummer ABIN2688976
  • Target Alle Angiotensin I Converting Enzyme 1 (ACE) Antikörper anzeigen
    Angiotensin I Converting Enzyme 1 (ACE) (Angiotensin I Converting Enzyme (Peptidyl-Dipeptidase A) 1 (ACE))
    Reaktivität
    • 104
    • 56
    • 48
    • 21
    • 11
    • 7
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    Human
    Wirt
    • 90
    • 30
    • 3
    • 1
    • 1
    Maus
    Klonalität
    • 84
    • 41
    Monoklonal
    Konjugat
    • 58
    • 14
    • 7
    • 4
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    Dieser Angiotensin I Converting Enzyme 1 Antikörper ist unkonjugiert
    Applikation
    • 90
    • 42
    • 42
    • 29
    • 26
    • 26
    • 12
    • 11
    • 10
    • 7
    • 6
    • 5
    • 3
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    Flow Cytometry (FACS)
    Marke
    BD Pharmingen™
    Produktmerkmale
    The BB9 Monoclonal antibody specifically binds Angiotensin-converting enzyme (ACE) which is also known as Dipeptidyl carboxypeptidase 1 (DCP1) or CD143. CD143 is a type I transmembrane glycoprotein that functions as a zinc metallopeptidase involved with the metabolism of angiotensin, bradykinin, and other oligopeptides. It is expressed on primitive hematopoietic progenitor cells (HPC). BB9 reacts with stromal cells, a minor subset of human bone marrow cells, it does not react with peripheral blood leucocytes. BB9 recognizes a subset of CD34+CD90+ cells that demonstrate low or absent expression of CD38, low retention of Rhodamine 123 and are Ki-67-negative. CD34+BB9+ cells are able to sustain hematopoiesis in pre-CFU culture stimulated with IL-3, IL-6, G-CSF, and SCF. BB9 also reacts with a subset of CD34+ cells from mobilized peripheral blood. This antibody was generated using human bone marrow-derived stromal cells as immunogen. Flow cytometric analysis of CD143 expression on human bone marrow cells. Human bone marrow cells were stained with APC Anti-Human CD34 (hematopoietic progenitor cell marker) and Purified Mouse Anti-Human Angiotensin Converting Enzyme (CD143) followed by FITC Goat Anti-Mouse IgG/IgM (Cat. No. 555988). The fluorescence histograms were derived from gated events with the forward and side light-scatter characteristics of viable cells. Flow cytometric analysis of CD143 expression on human bone marrow cell line. HEL 92.1.7 (Human bone marrow erythroblast, ATCC TIB-180) cells were stained with either Purified Mouse IgG1, κ Isotype Control (Cat. No. 555746, Dashed line histogram) or Purified Mouse Anti-Human Angiotensin Converting Enzyme (CD143) (Solid line historgram), followed by FITC Goat Anti-Mouse IgG/IgM (Cat. No. 555988). The fluorescence histograms were derived from gated events with the forward and side light-scatter characteristics of viable cells.

    BD Pharmingen™ Purified Mouse Anti-Human Angiotensin Converting Enzyme (CD143) - Purified - Clone BB9 - Isotype Mouse IgG1, κ - Reactivity Hu - 0.1 mg
    Aufreinigung
    The monoclonal antibody was purified from tissue culture supernatant or ascites by affinity chromatography.
    Immunogen
    Human bone marrow-derived stromal cells
    Klon
    BB9
    Isotyp
    IgG1 kappa
    Top Product
    Discover our top product ACE Primärantikörper
  • Applikationshinweise
    Optimal working dilution should be determined by the investigator.
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Konzentration
    0.5 mg/mL
    Buffer
    Aqueous buffered solution containing ≤0.09 % sodium azide.
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    4 °C
    Informationen zur Lagerung
    Store undiluted at 4°C.
  • Sinka, Biasch, Khazaal, Péault, Tavian: "Angiotensin-converting enzyme (CD143) specifies emerging lympho-hematopoietic progenitors in the human embryo." in: Blood, Vol. 119, Issue 16, pp. 3712-23, (2012) (PubMed).

    Zambidis, Park, Yu, Tam, Levine, Yuan, Pryzhkova, Péault: "Expression of angiotensin-converting enzyme (CD143) identifies and regulates primitive hemangioblasts derived from human pluripotent stem cells." in: Blood, Vol. 112, Issue 9, pp. 3601-14, (2008) (PubMed).

    Jokubaitis, Sinka, Driessen, Whitty, Haylock, Bertoncello, Smith, Péault, Tavian, Simmons: "Angiotensin-converting enzyme (CD143) marks hematopoietic stem cells in human embryonic, fetal, and adult hematopoietic tissues." in: Blood, Vol. 111, Issue 8, pp. 4055-63, (2008) (PubMed).

  • Target
    Angiotensin I Converting Enzyme 1 (ACE) (Angiotensin I Converting Enzyme (Peptidyl-Dipeptidase A) 1 (ACE))
    Andere Bezeichnung
    CD143 (ACE Produkte)
    Hintergrund
    Synonyms: ACE1, DCP1, Kininase II
    Pathways
    ACE Inhibitor Pathway, Peptide Hormone Metabolism, Regulation of Systemic Arterial Blood Pressure by Hormones, Feeding Behaviour, Smooth Muscle Cell Migration
Sie sind hier:
Kundenservice